The South Australian immunoGENomics Cancer Institute (SAiGENCI) is on the leading-edge of cancer research. It is an independent medical research institute embedded within the University of Adelaide.  With world-leading expertise, cutting-edge technologies and multidisciplinary collaborations, SAiGENCI is creating a world-class cancer research discovery hub that will deliver better outcomes for patients with cancer, their families, and everyone who has been or may be impacted by cancer. “Cancer is the competition, and we can only control cancer if we all work together as a team. Researchers cannot do this alone. We need industry and government collaborators, consumer advocates, supporters and donors – everyone coming together to fight cancer,” – Professor Chris Sweeney, SAiGENCI Director. With the advent of new technologies and new therapies we now have a lot of learnings and understandings of what drives cancer. There are also many new treatment options for people with cancer. However